首页> 中文期刊> 《中国生化药物杂志》 >普米克令舒雾化吸入治疗小儿急性感染性喉炎的临床疗效观察

普米克令舒雾化吸入治疗小儿急性感染性喉炎的临床疗效观察

         

摘要

Objective To discuss the clinical effect of pulmicort respules inhalation in children with acute infectious laryngitis.Methods We selected acute infectious laryngitis in our hospital from November 2015 to November 2016,106 children were divided into two groups,the control group and the observation group of 53 cases,of which the control group of children with conventional treatment,the observation group to take Pulmicort respules inhalation treatment,the two comparison(P<0.05).The total effective rate of the observation group and the control group were 100%and 90.56%respectively(P<0.05).Results The treatment effect of the observation group and the control group were observed and compared(P<0.05),and the improvement of the observation group after treatment and the time of symptom extinction were significantly better than that of the control group(P<0.05); The clinical symptoms of both groups before and after treatment were improved(P<0.05).Conclusion The treatment of children with acute infectious laryngitis by atomizing inhalation of pulmicort respules can obtain obvious therapeutic effect and reduce the adverse reaction caused by improper use of drugs,(fever,cough,wheezing,etc.)have a good improvement in clinical application worthy of recognition.%目的 讨论普米克令舒雾化吸入治疗小儿急性感染性喉炎的临床疗效观察.方法 选取浙江省温岭市第四人民医院2015年11月~2016年11月浙江省温岭市第四人民医院接诊的小儿急性感染性喉炎患儿106 例,随机分成对照组与观察组,各53 例,其中对照组患儿进行常规的治疗方法,观察组患儿采取普米克令舒雾化吸入方式进行治疗,对两个比较组的治疗效果进行观察和对比.结果 观察组和对照组的临床总有效率分别为100%和90.56%( P <0.05);通过对治疗前后2组患儿的临床表现的评估知治疗后2组患儿情况都有改善情况( P <0.05),且观察组治疗后的改善情况以及症状消失时间明显的优于对照组( P <0.05).结论 对于小儿急性感染性喉炎采用普米克令舒雾化吸入方法进行治疗能够取得明显的治疗效果,减轻了因为用药不当带来的不良反应,对临床症状(发热、咳嗽、喘息等)有很好的改善,临床应用价值值得肯定.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号